There are multiple strategies to develop AAV vectors, but typical steps include plasmid development and production, cell expansion, plasmid transfection, viral vector production, purification, and fill and finish. A transient transfection strategy for AAV production in either adherent or suspension cell lines is most common in pre-clinical and early phase development. Transfection Kits aim to improve transfection efficiency and cell survival.

The global AAV Transfection Kits market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on AAV Transfection Kits volume and value at the global level, regional level and company level. From a global perspective, this report represents overall AAV Transfection Kits market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global AAV Transfection Kits Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Small Size Packaging
Medium Size Packaging
Large Size Packaging

Segment by Application
Laboratory
GMP
Commercial

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Thermo Fisher
Mirus Bio (Gamma)
Polyplus-transfection
Polysciences
Takara
Hanbio Biotechnology Co